The US Has Announced The Possibility Of Creating Hundreds Of Millions Of Doses Of Vaccines Against COVID-19 By 2021
Leading US infectious disease specialist Anthony Fauci believes that by January next year, hundreds of millions of doses of the COVID-19 coronavirus vaccine may be ready in the US, NBC reported on Thursday.
"I think so," Fauci said, answering a question from a TV reporter about whether it is possible to prepare hundreds of millions of doses of the COVID-19 vaccine by January.
"We want to act quickly, but at the same time we want to make sure that it (the if vaccine) is safe and effective," Fauci added. "I think it can be done if everything works out."
In addition, Fauci recalled that earlier this year he already announced the timing of the creation of a vaccine and January 2021 is not so far from his initial forecasts.
"I said in January or February that it (creating a vaccine - if) will take from a year to 18 months, in January (2021 - if) it will just be a year," Fauci said.
The readiness of the vaccine by the beginning of next year depends on the result of its clinical trials. Companies such as Johnson & Johnson, Moderna, and the University of Oxford are working on developing the vaccine.
As the New York Times reported this week, the Oxford team probably has more progress in creating a vaccine. The University team is expected to prepare the first few million doses of the vaccine by September, at best.
Earlier on Thursday, Bloomberg reported that, according to its sources, the administration of US President Donald Trump is trying to implement the project "Operation supersonic speed," which aims to unite private pharmaceutical companies, government agencies and the military to try to reduce the development time of a coronavirus vaccine by eight months.
One of the Agency's interlocutors clarified that the goal of the project is to get 300 million doses of the vaccine by January 2021. It is noted that "Operation supersonic speed" will use government resources to quickly test the world's most promising experimental vaccines in animals, and then begin coordinated clinical trials in humans.
The project will cost billions of dollars, said one of the Agency's interlocutors. He clarified that the project will be funded from funds already available to the government.